Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 4449-4452, September 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luk, G. D.
Right arrow Articles by Hyland, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luk, G. D.
Right arrow Articles by Hyland, J.

Kinetic Changes in Mucosal Ornithine Decarboxylase Activity during Azoxymethane-induced Colonic Carcinogenesis in the Rat1

Gordon D. Luk2, Stanley R. Hamilton, Peter Yang, Jeffery A. Smith, Denis O'Ceallaigh, David McAvinchey and John Hyland

The Oncology Center and the Departments of Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

In the azoxymethane (AOM)-treated rat model of colonic carcinogenesis, serial injections of the carcinogen lead to the eventual development of colonic tumors. However, the precise nature of carcinogenesis events in this commonly used model is not well defined, and the occurrence of classic initiation and promotion phases after serial injections is uncertain. Since increases in ornithine decarboxylase (ODC) activity have been associated with promotion in other tumor models, we measured mucosal ODC during AOM carcinogenesis in the rat. We gave male Fischer 344 rats ten weekly injections of AOM at a dose of 3 mg/kg (Wk 1–10) and measured colonic mucosal ODC activity during the entire 25-wk course. Colonic tumor incidence at Wk 25 was 0% in controls and 48% in AOM animals (15 of 31). Mucosal ODC in AOM animals was significantly increased over controls. The time course of changes in mucosal ODC was similar throughout the entire colon and differed generally in magnitude only. Distinct and prolonged increases in ODC activity occurred within 4 h of a single injection of carcinogen and persisted for at least 14 days. With a second AOM injection on Day 7, there was another distinct and prolonged increase in ODC over the persistently elevated activity. Over the entire 25 wk, the increase in ODC was distinctly biphasic, higher at Wk 2, 11, and 13 than at Wk 6, 17, 21, and 25. The findings indicate that AOM induces an increase in mucosal ODC during colonic carcinogenesis, and they suggest that this carcinogenesis model, with ten weekly injections of carcinogen, has the properties of a multistep process. The early peak in ODC might be associated with the early carcinogenesis (initiation) phase(s), and a subsequent second increase in ODC might be associated with late carcinogenesis (post-initiation or promotion) phase(s). These results strengthen the utility of the rat AOM colonic carcinogenesis model for further studies of the role of ODC and polyamine metabolism in neoplastic transformation.

1 Supported in part by Grants CA-37789, CA-37606, and CA-34453 from the NIH and by the Clayton Fund. Portions of this work were presented in abstract form at the American Gastroenterological Association annual meeting, May 1982, Chicago (1).

2 Recipient of a Faculty Research Award from the American Cancer Society and an American Gastroenterological Association/Robins Research Scholar Award. To whom requests for reprints should be addressed, at Room 2-127, The Oncology Center, The Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD 21205.

Received 1/31/86. Revised 5/ 8/86. Accepted 5/15/86.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
H. Li, H. A.J. Schut, P. Conran, P. M. Kramer, R. A. Lubet, V. E. Steele, E. E. Hawk, G. J. Kelloff, and M. A. Pereira
Prevention by aspirin and its combination with {alpha}-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon
Carcinogenesis, March 1, 1999; 20(3): 425 - 430.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.